Trial intelligence / Profile preview

Fospropofol vs Propofol vs Etomidate for induction in emergency intracerebral hemorrhage surgery

ChiCTR2500107062Phase 4Not yet recruiting

Sponsor
Hainan People's Hospital
Start
Aug 2025
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fospropofol disodium in intracerebral hemorrhage (ICH) (3 arms), sponsored by Hainan People's Hospital. Primary endpoint: Incidence of post-induction hypotension. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

fospropofol disodium
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on ChiCTR2500107062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call